Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Sheba Begins Clinical Trial for INSPIRA Technologies’ Innovative HYLA Blood Sensor

Blood Sensor
The new non-invasive technology to monitor blood oxygen levels will be applied in operating rooms at Sheba’s Department of Cardiac Surgery

Sheba Medical Center will begin a new clinical trial for the HYLA blood sensor developed by INSPIRA Technologies. The trial, led by Dr. Yigal Kassif, Sheba’s principal investigator, will take place in the operating rooms of Sheba’s Department of Cardiac Surgery. 

“Sheba Medical Center focuses on quality clinical research programs of key medical advancements to improve patient outcomes worldwide. INSPIRA Technologies’ HYLA blood sensor technology has significant potential to enhance real-time patient monitoring,” Dr. Kassif said. 

The HYLA blood sensor provides surgeons with real-time oxygen measurements by continuously monitoring blood gas levels. Doctors can then be alerted to sudden changes as soon as they occur and take immediate action – improving treatment outcomes as well as reducing the risk of complications.

The study aims to evaluate the HYLA blood sensor in an operating room setting, specifically when used to monitor patients undergoing open heart surgery while connected to a cardiopulmonary bypass machine. “The HYLA blood sensor is designed for multiple hospital settings, both inside and outside the operating room,” says the CEO of INSPIRA Technologies, Dagi Ben-Noon. In the future, HYLA will be integrated with INSPIRA’s Augmented Respiration Technology (ART) to replace traditional mechanical ventilation systems with non-invasive oxygen support. 

As Israel’s leading medical research facility, Sheba is dedicated to promoting healthcare innovation through technologies such as the HYLA blood sensor, which will hopefully facilitate a future where medical care is more accessible, effective, and safe.

News Mar 26.
West Bank and Gaza Medical Professionals Attend a Milestone Sheba Oncology Conference
Highlighting the latest in cancer care, with a particular focus on pediatrics, the Recent Advances in Cancer Care (REACT) 2023 event was attended by over…
Read More
Isenia’s Battle
Isenia’s Battle with Alveolar Sarcoma
At 17, Isenia, a native of Semey, Kazakhstan, noticed a lump on her leg the size of a small apple. Initially, Isenia and her family…
Read More
Colon and Rectal Cancer
News Mar 14.
Sheba Study Indicates Readily-Available Drugs May Prevent Metastasis in Colon and Rectal Cancer Patients
Favorable responses to the treatment were noted by Prof. Shamgar Ben-Eliyahu, a neuroscientist specializing in psychoneuroimmunology (PNI) at TAU’s Sagol School of Neuroscience and School…
Read More